import { Metadata } from 'next'
import Link from 'next/link'
import Breadcrumbs from '@/components/Breadcrumbs'
import ShareButtons from '@/components/ShareButtons'
import ArticleSchema from '@/components/ArticleSchema'
import RelatedAnalysis from '@/components/RelatedAnalysis'

export const metadata: Metadata = {
  title: 'How We Score Prescribing Risk: Specialty-Adjusted Peer Comparison',
  description: 'Our 10-component risk scoring model combines specialty-adjusted z-scores, population percentiles, drug combination analysis, and OIG exclusion matching across 1.38M providers.',
  alternates: { canonical: 'https://www.openprescriber.org/analysis/fraud-risk-methodology' },
}

export default function FraudRiskMethodologyPage() {
  return (
    <div className="max-w-4xl mx-auto px-4 py-10">
      <ArticleSchema
        title="How We Score Prescribing Risk"
        description="Our 10-component risk scoring model combines specialty-adjusted z-scores, population percentiles, and drug combination analysis."
        slug="fraud-risk-methodology"
        date="2026-02-27"
      />
      <Breadcrumbs items={[{ label: 'Analysis', href: '/analysis' }, { label: 'Risk Scoring Methodology' }]} />
      <h1 className="text-3xl font-bold font-[family-name:var(--font-heading)] mb-4">How We Score Prescribing Risk</h1>
      <ShareButtons title="How We Score Prescribing Risk ‚Äî OpenPrescriber" />

      <div className="prose prose-gray max-w-none mt-6">
        <p className="text-lg text-gray-600">
          OpenPrescriber uses a unified 10-component risk scoring model that combines two complementary approaches: <strong>specialty-adjusted peer comparison</strong> (how far does a provider deviate from others in their specialty?) and <strong>population-level analysis</strong> (where do they fall nationally?). This dual approach avoids the critical flaw of universal thresholds and produces more accurate results than either method alone.
        </p>

        <div className="not-prose grid grid-cols-2 md:grid-cols-4 gap-3 my-8">
          <div className="bg-blue-50 rounded-xl p-4 text-center border border-blue-200">
            <p className="text-2xl font-bold text-blue-700">10</p>
            <p className="text-xs text-blue-600">Risk Components</p>
          </div>
          <div className="bg-blue-50 rounded-xl p-4 text-center border border-blue-200">
            <p className="text-2xl font-bold text-blue-700">110</p>
            <p className="text-xs text-blue-600">Specialties Profiled</p>
          </div>
          <div className="bg-red-50 rounded-xl p-4 text-center border border-red-200">
            <p className="text-2xl font-bold text-red-700">233</p>
            <p className="text-xs text-red-600">High Risk (‚â•50)</p>
          </div>
          <div className="bg-orange-50 rounded-xl p-4 text-center border border-orange-200">
            <p className="text-2xl font-bold text-orange-700">6,473</p>
            <p className="text-xs text-orange-600">Elevated (‚â•30)</p>
          </div>
        </div>

        <h2>Why Specialty-Adjusted Scoring?</h2>
        <p>
          Most fraud detection tools use <strong>universal thresholds</strong> ‚Äî for example, flagging anyone with an opioid prescribing rate above 20%. This approach generates massive false positives. A pain management specialist at 50% opioid prescribing is entirely normal for their field. A family doctor at 50% is 13 standard deviations above their specialty average ‚Äî a genuinely extreme outlier.
        </p>
        <p>
          Our model computes baseline statistics (mean, standard deviation, percentile distributions) for <Link href="/specialty-profiles" className="text-primary hover:underline">110 medical specialties</Link>. Each provider is then scored against their own specialty peers. This means a pain management doctor is compared to other pain management doctors, an oncologist to other oncologists, and a family physician to other family physicians.
        </p>
        <p>
          The technical implementation uses <strong>z-scores</strong> ‚Äî the number of standard deviations a provider&apos;s metric falls above or below their specialty mean. A z-score of 2 means the provider is roughly in the top 2-3% of their specialty. A z-score of 5 means they&apos;re far beyond what any normal clinical variation can explain.
        </p>

        <h2>The 10 Scoring Components</h2>
        <p>Each component contributes points to a composite score (max 100). Points are additive, with a volume multiplier applied at the end.</p>

        <h3>1. Specialty-Adjusted Opioid Rate (0‚Äì25 points)</h3>
        <p>
          The most important component. We compute each provider&apos;s opioid prescribing z-score against their specialty. A family doctor with 3.78% mean opioid rate (œÉ=10.2) gets flagged very differently than a pain management specialist with a 35.3% mean (œÉ=22.1).
        </p>
        <ul>
          <li><strong>&gt;5œÉ above peers:</strong> 25 points (extreme ‚Äî virtually impossible by chance)</li>
          <li><strong>&gt;3œÉ above peers:</strong> 18 points (very high ‚Äî top ~0.1% of specialty)</li>
          <li><strong>&gt;2œÉ above peers:</strong> 10 points (high ‚Äî top ~2% of specialty)</li>
        </ul>

        <h3>2. Population Percentile Opioid Rate (0‚Äì15 points)</h3>
        <p>
          Independent of specialty, we check where the provider falls in the <strong>national distribution</strong> of all 433,324 providers with opioid claims. This catches cases where a specialty itself has unusual norms.
        </p>
        <ul>
          <li><strong>99th percentile</strong> (rate &gt;70.6%): 15 points</li>
          <li><strong>95th percentile</strong> (&gt;50.3%): 10 points</li>
          <li><strong>90th percentile</strong> (&gt;37.2%): 5 points</li>
        </ul>

        <h3>3. Cost Outlier (0‚Äì10 points)</h3>
        <p>
          Requires a <strong>dual condition</strong>: the provider must be high both in population percentile AND relative to their specialty peers (z-score). This prevents flagging oncologists whose high costs are normal for their field.
        </p>

        <h3>4. Brand-Name Preference (0‚Äì8 points)</h3>
        <p>
          Flags providers prescribing far more <Link href="/brand-vs-generic" className="text-primary hover:underline">brand-name drugs</Link> than their specialty peers. Only triggered when z-score exceeds 2‚Äì3 AND the absolute brand percentage exceeds 30‚Äì50%. This avoids flagging specialties where brand-name drugs are clinically necessary.
        </p>

        <h3>5. Long-Acting Opioid Rate (0‚Äì8 points)</h3>
        <p>
          Long-acting opioids (OxyContin, MS Contin, fentanyl patches) carry higher diversion and abuse potential. We flag providers whose long-acting opioid share exceeds 3 standard deviations above their specialty mean.
        </p>

        <h3>6. Elderly Antipsychotic Prescribing (0‚Äì10 points)</h3>
        <p>
          CMS specifically tracks <Link href="/analysis/antipsychotic-elderly" className="text-primary hover:underline">antipsychotic prescribing to patients 65+</Link> as a quality concern ‚Äî these drugs carry FDA Black Box Warnings for increased mortality in elderly dementia patients.
        </p>

        <h3>7. Opioid + Benzodiazepine Co-Prescribing (0‚Äì8 points)</h3>
        <p>
          By analyzing the full <strong>11.9 million-row provider-drug dataset</strong>, we identify providers who prescribe both opioids and benzodiazepines. The FDA issued a <Link href="/dangerous-combinations" className="text-primary hover:underline">Black Box Warning</Link> about this combination due to life-threatening respiratory depression. We identified <strong>6,149 co-prescribers</strong>.
        </p>

        <h3>8. OIG Exclusion Match (0‚Äì20 points)</h3>
        <p>
          We cross-reference every provider NPI against the Office of Inspector General&apos;s <Link href="/excluded" className="text-primary hover:underline">List of Excluded Individuals/Entities (LEIE)</Link> ‚Äî individuals convicted of healthcare fraud, patient abuse, or related offenses. We found <strong>372 excluded providers still actively prescribing</strong> in Medicare Part D.
        </p>

        <h3>9. Low Drug Diversity (0‚Äì5 points)</h3>
        <p>
          Providers who prescribe a very narrow range of drugs (‚â§5‚Äì10 unique medications) while also prescribing opioids may indicate a &ldquo;pill mill&rdquo; operation rather than a genuine medical practice. Legitimate practices typically prescribe across a broad range of drug categories.
        </p>

        <h3>10. High Fills Per Patient (0‚Äì5 points)</h3>
        <p>
          Providers whose patients average more than 15‚Äì20 prescription fills per year may indicate over-prescribing or patients being used as conduits for drug diversion. This metric is specialty-adjusted to account for fields like psychiatry where multiple maintenance medications are common.
        </p>

        <h2>Volume Adjustments</h2>
        <p>Two volume-related adjustments improve accuracy:</p>
        <ul>
          <li><strong>Minimum threshold:</strong> Providers with fewer than 100 claims are excluded entirely ‚Äî too little data for meaningful statistical analysis.</li>
          <li><strong>Low-volume cap:</strong> Providers with 100‚Äì200 claims have their percentile-based flags capped at 60% ‚Äî acknowledging higher statistical noise.</li>
          <li><strong>High-volume multiplier:</strong> Providers with &gt;5,000 claims receive a 15% score boost, because the same risky patterns at scale affect vastly more patients. Providers with &gt;2,000 claims get 5%.</li>
        </ul>

        <h2>Risk Levels</h2>
        <div className="not-prose grid grid-cols-2 md:grid-cols-4 gap-3 my-4">
          <div className="bg-red-50 rounded-lg p-3 text-center border border-red-200">
            <p className="font-bold text-red-700">üî¥ High (‚â•50)</p>
            <p className="text-xs text-gray-600">233 providers</p>
          </div>
          <div className="bg-orange-50 rounded-lg p-3 text-center border border-orange-200">
            <p className="font-bold text-orange-700">üü† Elevated (30‚Äì49)</p>
            <p className="text-xs text-gray-600">6,473 providers</p>
          </div>
          <div className="bg-yellow-50 rounded-lg p-3 text-center border border-yellow-200">
            <p className="font-bold text-yellow-700">üü° Moderate (15‚Äì29)</p>
            <p className="text-xs text-gray-600">43,120 providers</p>
          </div>
          <div className="bg-green-50 rounded-lg p-3 text-center border border-green-200">
            <p className="font-bold text-green-700">üü¢ Low (0‚Äì14)</p>
            <p className="text-xs text-gray-600">842,305 providers</p>
          </div>
        </div>

        <h2>What This Looks Like in Practice</h2>
        <p>Consider our highest-scoring provider (77/100): an internal medicine doctor who:</p>
        <ul>
          <li>Prescribes opioids at 62% of claims ‚Äî <strong>2,687% above</strong> the internal medicine average of 2.2%</li>
          <li>Co-prescribes opioids and benzodiazepines (FDA Black Box Warning combination)</li>
          <li>Appears on the OIG exclusion list (convicted of healthcare offense)</li>
          <li>Prescribes only 6 unique drugs (extremely low diversity)</li>
          <li>Has elevated long-acting opioid prescribing vs peers</li>
        </ul>
        <p>
          Every single component is transparent and explainable. You can see exactly why they scored 77 ‚Äî 25 points for extreme opioid vs peers, 10 for 95th percentile nationally, 20 for LEIE exclusion, 8 for opioid+benzo combo, 8 for LA opioid, 3 for elevated cost, and 3 for low diversity.
        </p>
        <p>
          Explore flagged providers yourself on the <Link href="/risk-explorer" className="text-primary hover:underline">Risk Explorer</Link>, or see the full <Link href="/flagged" className="text-primary hover:underline">flagged providers list</Link>.
        </p>

        <h2>Key Limitations</h2>
        <ul>
          <li><strong>No clinical context:</strong> We cannot see diagnoses, treatment plans, or medical necessity. High opioid rates may be entirely appropriate for hospice, palliative care, or addiction treatment.</li>
          <li><strong>Specialty misclassification:</strong> If CMS lists a provider under the wrong specialty, the peer comparison may be inaccurate.</li>
          <li><strong>Single-year snapshot:</strong> 2023 data only ‚Äî providers may have changed practices since then.</li>
          <li><strong>Right-skewed distributions:</strong> Some specialties (like NPs, with mean 3.8% and œÉ=10.2%) have highly skewed distributions where the standard deviation is larger than the mean. Z-scores work less well for heavily skewed data.</li>
          <li><strong>Correlation ‚â† fraud:</strong> Statistical outliers are not inherently problematic. Our scores identify unusual patterns, not bad actors.</li>
        </ul>

        <h2>Machine Learning Extension</h2>
        <p>
          Beyond the rule-based model, OpenPrescriber now includes a <strong>machine learning fraud detection system</strong> trained on 281 confirmed fraud cases from the OIG LEIE exclusion list. The ML model ‚Äî a Bagged Decision Trees ensemble ‚Äî analyzes the same 20 features and identifies <strong>non-obvious pattern combinations</strong> that hand-tuned rules miss.
        </p>
        <p>
          The ML model flagged <strong>4,100+ providers</strong> at ‚â•80% confidence. Cross-validated performance: 83% precision, 66.6% recall. See the <Link href="/ml-fraud-detection" className="text-primary hover:underline">ML Fraud Detection page</Link> for full results and the complete list of flagged providers.
        </p>

        <div className="not-prose mt-8 bg-blue-50 border border-blue-200 rounded-lg p-4 space-y-2">
          <p className="text-sm text-blue-800 font-medium">Explore the Models</p>
          <div className="flex flex-wrap gap-2">
            <Link href="/risk-explorer" className="text-sm text-primary hover:underline">üîç Risk Explorer</Link>
            <Link href="/ml-fraud-detection" className="text-sm text-primary hover:underline">ü§ñ ML Fraud Detection</Link>
            <Link href="/flagged" className="text-sm text-primary hover:underline">üî¥ Flagged Providers</Link>
            <Link href="/methodology" className="text-sm text-primary hover:underline">üìã Full Methodology</Link>
            <Link href="/peer-comparison" className="text-sm text-primary hover:underline">üìä Peer Comparison</Link>
            <Link href="/specialty-profiles" className="text-sm text-primary hover:underline">‚öïÔ∏è Specialty Profiles</Link>
          </div>
        </div>

        <div className="mt-8 text-xs text-gray-400 border-t pt-4">
          <p>Data: CMS Medicare Part D (2023), OIG LEIE. Risk scores are computed by OpenPrescriber for informational purposes. They do not constitute allegations of fraud, abuse, or inappropriate prescribing.</p>
        </div>
      <RelatedAnalysis current={"/analysis/fraud-risk-methodology"} />
      </div>
    </div>
  )
}
